Clinical Trial Update: A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [Phase 2]

View source ↗

Summary

Phase 2 study evaluating three anti-HIV drug combinations in patients who have taken amprenavir; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED